or Try an Advanced Search...

    Technical Analysis for NEXI - NexImmune, Inc.

    Grade Last Price % Change Price Change
    F 0.22 5.87% 0.01
    NEXI closed down 17.79 percent on Tuesday, November 19, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NEXI trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 5.87%
    Fell Below 20 DMA Bearish 5.87%
    Stochastic Reached Oversold Weakness 5.87%
    Wide Bands Range Expansion 5.87%
    Oversold Stochastic Weakness 5.87%
    50 DMA Resistance Bearish -12.96%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -12.96%
    Earnings Movers Other -12.96%
    Wide Bands Range Expansion -12.96%
    Fell Below 50 DMA Bearish -12.96%
    Older End-of-Day Signals for NEXI ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    Possible Inside Day about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NEXI Chart by TradingView
    Basic chart:

    Profile

    NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

    Is NEXI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.6949
    52 Week Low 0.2
    Average Volume 3,284
    200-Day Moving Average 3.19
    50-Day Moving Average 0.28
    20-Day Moving Average 0.25
    10-Day Moving Average 0.24
    Average True Range 0.08
    RSI (14) 43.50
    ADX 37.26
    +DI 40.01
    -DI 14.95
    Chandelier Exit (Long, 3 ATRs) 0.18
    Chandelier Exit (Short, 3 ATRs) 0.44
    Upper Bollinger Bands 0.33
    Lower Bollinger Band 0.16
    Percent B (%b) 0.27
    BandWidth 69.92
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.0094
    Fundamentals Value
    Market Cap 270.92 Thousand
    Num Shares 1.3 Million
    EPS -42.05
    Price-to-Earnings (P/E) Ratio 0.00
    Price-to-Sales 0.00
    Price-to-Book 1.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.34
    Resistance 3 (R3) 0.35 0.32 0.32
    Resistance 2 (R2) 0.32 0.29 0.32 0.31
    Resistance 1 (R1) 0.27 0.27 0.25 0.25 0.30
    Pivot Point 0.24 0.24 0.23 0.23 0.24
    Support 1 (S1) 0.18 0.20 0.16 0.17 0.11
    Support 2 (S2) 0.15 0.18 0.14 0.11
    Support 3 (S3) 0.09 0.15 0.10
    Support 4 (S4) 0.08